Doximity Faces Class Action Lawsuit Following Stock Price Declines
Investors who purchased Doximity, Inc. common stock between August 8, 2024, and May 13, 2026, face a November 16, 2026, deadline to seek appointment as lead plaintiff in a class action lawsuit. The case, filed in the Northern District of California, accuses the company of misleading shareholders regarding its growth prospects.
By Money Talk·September 18, 2026·2 min read·501 reads
The litigation, Michigan Laborers' Pension Fund v. Doximity, Inc., alleges that the digital medical platform and its executives violated the Securities Exchange Act of 1934. According to the complaint, Doximity overstated the revenue-generating potential of its Newsfeed while losing market share to competitors. The suit claims the firm relied on basic banner ads and e-newsletters rather than the deep engagement tactics originally touted to investors.
The company’s stock price suffered three significant declines during the period identified in the complaint. Shares dropped 13% on November 6, 2025, after management expressed caution regarding ad spending. A 17% decline followed on February 5, 2026, when Doximity lowered its revenue guidance and reported decelerating sales growth. The stock fell another 23% on May 13, 2026, after the company missed its revised targets and projected slower growth for the 2027 fiscal year.
Investors wishing to serve as lead plaintiff must demonstrate a substantial financial interest in the outcome. Those interested in the process can contact attorneys Ken Dolitsky or Michael Albert at Robbins Geller Rudman & Dowd LLP, the firm representing the plaintiffs.
Comments (0)
No comments yet. Be the first!